Skip to main content
SpringerLink
Log in

Mixed results for a malaria vaccine

  • Community Corner
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. The RTS,S Cinical Trials Partnership. first results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N. Engl. J. Med. published online, 10.1056/nejmoa1102287 (18 October 2011).

  2. Cohen, J., Nussenzweig, V., Nussenzweig, R., Vekemans, J. & Leach, A. From the circumsporozoite protein to the RTS, S vaccine. Hum. Vaccin. 6, 90–96 (2010).

    Article  CAS  PubMed  Google Scholar 

  3. Stewart, V.A. et al. Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone. Infect. Immun. 75, 2283–2290 (2007).

    Article  CAS  PubMed  Google Scholar 

  4. Bojang, K.A. et al. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 358, 1927–1934 (2001).

    Article  CAS  PubMed  Google Scholar 

  5. Good, M.F. Our impasse in developing a malaria vaccine. Cell. Mol. Life Sci. 68, 1105–1113 (2011).

    Article  CAS  PubMed  Google Scholar 

  6. Barry, A.E., Schultz, L., Buckee, C.O. & Reeder, J.C. et al. Contrasting population structures of the genes encoding ten leading malaria vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum. PLoS One 4, e8497 (2009).

    Article  PubMed  Google Scholar 

  7. Bejon, P. et al. Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N. Engl. J. Med. 359, 2521–2532 (2008).

    Article  CAS  PubMed  Google Scholar 

  8. Asante, K.P. et al. Safety and efficacy of the RTS,S/AS01(E) candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. Lancet Infect. Dis. 11, 741–749 (2011).

    Article  CAS  PubMed  Google Scholar 

  9. Moorthy, V., Reed, Z. & Smith, P.G. Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation. Vaccine 25, 5115–5123 (2007).

    Article  CAS  PubMed  Google Scholar 

  10. Alonso, P.L. et al. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 366, 2012–2018 (2005).

    Article  CAS  PubMed  Google Scholar 

Download references

Ethics declarations

Competing interests

A.V.S.H. has collaborated with GlaxoSmithKline Biologicals in assessment of RTS,S vaccines and is a developer of other malaria vaccine candidates.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mixed results for a malaria vaccine. Nat Med 17, 1560–1561 (2011). https://doi.org/10.1038/nm1211-1560

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1211-1560

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation